LAS VEGAS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the market leader in cloud business management solutions, today kicks off its revamped annual conference for Sage Intacct customers. The ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with ...
Announced positive topline data from pivotal WATERFALL Study of zuranolone in patients with MDD showing statistically significant and clinically meaningful reduction in depressive symptoms at Day 15, ...
TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the market leader in cloud business management solutions, today announced the 2021 Sage Circle of Excellence Accounting Awards winners.
Throughout Sage Therapeutics’ development of zuranolone, the biotech has been consistent in the messaging for its experimental depression drug: Whereas existing therapies may require weeks to work and ...
TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the market leader in cloud business management solutions, today announced the 2021 Sage Circle of Excellence Accounting Awards winners. Over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback